Article
Substrate recognition by the human fatty-acid synthase.
The Journal of biological chemistry - 30 Dec 2005
Carlisle-Moore Loretha, Gordon Chris R, Machutta Carl A, Miller W Todd, Tonge Peter J
Abstract excerpt
The human fatty-acid synthase (HFAS) is a potential target for anti-tumor drug discovery. As a prelude to the design of compounds that target the enoyl reductase (ER) component of HFAS, the recognition of NADPH and exogenous substrates by the ER active site has been investigated. Previous studies demonstrate that modification of Lys-1699 by pyridoxal 5'-phosphate results in a specific decrease in ER activity. For...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
